Colorado sees decline in annual flu shots

Fewer people are receiving their yearly flu vaccinations at the same time that infections are rising and the new K variant of influenza is spreading. Data from the Colorado Department of Public Health and Environment show that only about twenty five percent of residents have been vaccinated so far this fall. That figure was twenty seven percent at this point last year and well below the thirty two percent reached over the full 2024 to 2025 season.

Health officials say misinformation about vaccines has reduced uptake across multiple immunizations. The drop comes during a concerning period, since the Type A H3N2 subclade K has surged internationally and caused significant early outbreaks in Japan, the United Kingdom and Canada. This same variant is now moving through Colorado and other parts of the United States.

Experts warn of a more severe season

According to Dr Michelle Barron, senior medical director for infection control and prevention at UCHealth, influenza continues to cause between twenty thousand and thirty thousand deaths per year in the country. She noted that the K variant has shown an ability to partly evade existing immunity and reduce the effectiveness of current vaccines.

Although this year’s shot does not perfectly match the K variant, Barron stressed that vaccination still provides critical protection and lowers the risk of severe disease. She advised people who have not yet received their flu shot to schedule it immediately as cases climb and travel increases during the holidays.

Why the K variant is different

Seasonal influenza strains mutate regularly. The H3N2 strain has changed more than usual this year, creating the subclade known as K. The mutations emerged after vaccine formulations were finalized, which complicates the ability of the shot to target the updated version of the virus.

Barron compared the mismatch to sending a package with an incorrect postal code. The vaccine still helps the immune system recognize influenza, but the updated strain can move more effectively through the community. Even with a mismatch, vaccinated individuals are less likely to require hospitalization or face life threatening complications.

Laboratory testing in Colorado shows that the K variant now represents the majority of samples submitted from hospitals, confirming its rapid spread across the state.

Falling vaccination rates raise concern

Declining uptake of flu, COVID nineteen and other routine vaccines worries physicians who expect more severe outcomes with lower community protection. Barron said that last year’s influenza season was especially deadly, with an estimated twenty seven thousand to one hundred thirty thousand deaths nationwide. The number of children who died from confirmed flu reached at least two hundred seventy nine, almost all of whom had been healthy before infection.

She urged families to speak with trusted medical providers rather than relying on misinformation circulating online. Lower vaccination rates, she said, will translate directly into more severe illness this season, especially for children, older adults and people with existing medical conditions.

A call to action for families

Barron emphasized that influenza remains dangerous for healthy children whose immune systems are still developing. She described it as devastating to see preventable deaths among young patients. Her message to families is direct and urgent. Make plans now to get vaccinated and protect vulnerable loved ones during what could be a difficult respiratory virus season.

Hybrid of two known clades raises monitoring concerns

Scientists have identified a new mpox strain that contains genetic elements from both clade Ib and clade IIb, creating a recombinant version of the virus that currently has no official name. The discovery comes as public health agencies across Europe report early signs of local transmission of clade Ib, prompting renewed vaccination reminders for gay, bisexual, and other men who have sex with men — groups considered at higher risk of exposure.

Clade IIb was responsible for the global mpox outbreak in 2022, which spread across dozens of countries. The UK continues to offer vaccination to those most at risk, including people with multiple sexual partners, those who attend group sex events, and individuals who visit sex on premises venues. Health officials say available vaccines offer an estimated 75 to 80 percent protection against mpox, though effectiveness against the new recombinant strain has not yet been studied.

Experts urge vaccination as genetic changes emerge

Dr Katy Sinka of the UK Health Security Agency said genomic surveillance enabled rapid detection of the recombinant strain, emphasizing that ongoing viral evolution is expected. She urged eligible groups to remain protected through vaccination, calling it a proven tool for preventing severe disease.

While the UK has robust identification and containment systems, global experts caution that this capacity is uneven worldwide. Professor Trudie Lang of the University of Oxford noted that vulnerable regions, particularly those with limited vaccine access, face greater challenges in tracking and controlling spread. Understanding how the new strain transmits and how severe its symptoms are will be essential if cases increase beyond current levels.

Global spread heightens concerns

Nearly 48,000 mpox cases have been confirmed worldwide in 2025, including 2,500 in the last month alone, with central Africa experiencing the highest burden. Dr Boghuma Titanji of Emory University warned that continued global circulation creates ideal conditions for the virus to recombine and adapt. Each new variant raises the risk of mpox becoming more firmly entrenched as a persistent human pathogen.

Mpox typically causes a rash or lesions lasting two to four weeks, often accompanied by fever, headaches, muscle aches and fatigue. Transmission occurs through close physical contact, contaminated materials, and respiratory droplets. UK health officials advise anyone who suspects they may have mpox to contact NHS 111 for guidance.